tiprankstipranks
Advertisement
Advertisement
AIM ImmunoTech Ends At-The-Market Equity Program
PremiumCompany AnnouncementsAIM ImmunoTech Ends At-The-Market Equity Program
1M ago
AIM ImmunoTech Stockholders Approve Key Equity Proposals
Premium
Company Announcements
AIM ImmunoTech Stockholders Approve Key Equity Proposals
2M ago
AIM ImmunoTech Regains NYSE American Listing Compliance
Premium
Company Announcements
AIM ImmunoTech Regains NYSE American Listing Compliance
3M ago
AIM ImmunoTech Inc trading halted, news pending
PremiumThe FlyAIM ImmunoTech Inc trading halted, news pending
3M ago
AIM ImmunoTech registers to sell 31.29M shares of common stock for holders
Premium
The Fly
AIM ImmunoTech registers to sell 31.29M shares of common stock for holders
3M ago
AIM ImmunoTech Highlights Ampligen’s Emerging Ebola Treatment Potential
Premium
Company Announcements
AIM ImmunoTech Highlights Ampligen’s Emerging Ebola Treatment Potential
3M ago
AIM ImmunoTech announces $2.4M registered direct offering
PremiumThe FlyAIM ImmunoTech announces $2.4M registered direct offering
4M ago
AIM ImmunoTech Inc trading halted, news pending
Premium
The Fly
AIM ImmunoTech Inc trading halted, news pending
4M ago
AIM ImmunoTech Strengthens Equity Position and Financial Flexibility
Premium
Company Announcements
AIM ImmunoTech Strengthens Equity Position and Financial Flexibility
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100